CJC-1295 (DAC Modification)
Long-acting, albumin-binding GHRH analog. DAC-modified 30-mer.
Endocrine & Cell Repair Research Peptides
AOD9604 is a modified fragment corresponding to the C-terminal lipolytic region (176–191) of human growth hormone, carrying a tyrosine substitution for stability. It retains the lipolytic activity of the parent hormone while lacking GH's growth-promoting and IGF-1-stimulating effects, and is studied as a targeted adipocyte-signaling research tool.
Research Use Only · Buyer verification required
Specifications
Documentation & Quality
Documentation is lot-specific. The statuses above describe what may be available, not a specific batch result. Lot-specific documentation is available with quotation or order. Please contact our team to confirm current documentation availability.
Request a QuoteRequest a Quote
Bulk quantities, custom purity, documentation, and packaging options are reviewed for qualified business buyers.
Long-acting, albumin-binding GHRH analog. DAC-modified 30-mer.
N-terminal 1–29 fragment of human GHRH. Shortest fully active form.
44-mer GHRH(1-44) analog with N-terminal hexenoyl cap.